Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Iron (parenteral Preparations), Atc B03ac01 F. D. Z. 01.11.2531.10.27 (plus Extension Option 1x12 Month) 2026-03-16
Germany Open-house Biologika Discount Contracts 2025-27-tencilizumab 2026-03-16
Germany Open House Pharmaceutical Discounts On The Active Ingredient Teriparatide, Atc H05aa02 2026-03-16
Germany Bitumen Examinations According To Tl Bitumen Stb And Studies On Bitumen Emulsions According To Tl 2026-03-16
Germany Openhouser Discount Contracts 202412 2026-03-16
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Filgotinib, Atc L04af04 For The Time 01.11.2025 31.10.2027 2026-03-16
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V To The Active Ingredient Sodium Phenylbutyrat, Atc A16ax03 For The Time 01.11.2025 31.10.2027 2026-03-16
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Iron (parenteral Preparations), Atc B03ac07 F. D. Z. 01.11.25-31.10.27 (plus Extension Option 1x12 Month) 2026-03-16
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Formoterol, Beclometason, Glycopyrronium, F. D. Z. 01.11.25 - 31.10.26 (plus Extension Option 1x12 Mon) 2026-03-16
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Formoterol, Beclometason, Glycopyrronium, F. D. Z. 01.11.25 - 31.10.26 (plus Extension Option 1x12 Mon) 2026-03-16
Whats app